Exact Sciences Corporatio...

NASDAQ: EXAS · Real-Time Price · USD
45.27
0.28 (0.62%)
At close: Aug 15, 2025, 9:59 AM

Exact Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.76B 2.5B 2.08B 1.77B
Cost of Revenue
840.15M 654.25M 574.39M 458.76M
Gross Profit
1.92B 1.85B 1.51B 1.31B
Operating Income
-1.05B -215.01M -577.54M -835.47M
Interest Income
-5.3M -5.35M 19.63M 1.79M
Pretax Income
-1.04B -201.75M -632.57M -842.51M
Net Income
-1.03B -204.15M -623.51M -595.63M
Selling & General & Admin
1.68B 1.62B 1.58B 1.66B
Research & Development
431.21M 425.88M 393.42M 385.65M
Other Expenses
868.06M -3.69M 110.69M 95M
Operating Expenses
2.97B 2.06B 2.09B 2.14B
Interest Expense
31.97M 24.42M 19.63M 18.61M
Selling & Marketing Expenses
894.13M 203.9M 846.01M 861.89M
Cost & Expenses
2.98B 2.71B 2.66B 2.6B
Income Tax Expense
-7.3M 2.4M -9.06M -246.88M
Shares Outstanding (Basic)
184.2M 180.14M 176.35M 171.35M
Shares Outstanding (Diluted)
184.2M 180.14M 176.35M 171.35M
EPS (Basic)
-5.59 -1.13 -3.54 -3.48
EPS (Diluted)
-5.59 -1.13 -3.54 -3.48
EBITDA
-788.73M 41.88M -386.74M -617.73M
EBIT
-1B -177.32M -618.66M -829.63M
Depreciation & Amortization
214.86M 206.61M 226.2M 206.17M